inspection – Page 266

Repeated Grade B excursions ignored during inspection period – inspection finding analysis

Analysis of Ignored Grade B Excursions During Inspection: A Case Study In a recent FDA inspection at a pharmaceutical manufacturing facility, repeated Grade B excursions were found to have been…

Personnel EM failures repeated during routine EM program – CAPA and monitoring redesign failure

Addressing Repeated Personnel EM Failures in Routine Environmental Monitoring Programs Environmental Monitoring (EM) is critical for maintaining the integrity and quality of pharmaceutical manufacturing environments. However, a recurring issue with…

Action limit excursion not investigated during routine EM program – inspection finding analysis

Case Study on Unaddressed Action Limit Excursion During Routine Environmental Monitoring Programs In the highly regulated pharmaceutical environment, adherence to established protocols is crucial for product quality and regulatory compliance.…

Unapproved chromatographic integration during investigation – CAPA failure exposed

Case Study: Addressing Unapproved Chromatographic Integration to Avoid CAPA Failures In a recent scenario at a pharmaceutical manufacturing facility, a GMP deviation emerged involving unapproved chromatographic integration during an investigation…

Sample preparation error during routine testing – regulatory enforcement risk

Case Study: Investigating Sample Preparation Errors in Routine Testing That Pose Regulatory Risks In the highly regulated pharmaceutical sector, even minor errors during sample preparation can lead to significant compliance…

Analyst training gap during routine testing – CAPA failure exposed

Training Shortcomings in Analysts Lead to Deviation in Routine Testing – A CAPA Investigation In the highly regulated pharmaceutical manufacturing environment, maintaining strict compliance with Good Manufacturing Practices (GMP) is…

Sample preparation error during data review – inspection citation explained

Examination of a Sample Preparation Error: Lessons Learned from a Quality Control Deviation In the highly regulated pharmaceutical environment, maintaining data integrity throughout the product lifecycle is paramount. A recent…

Analyst training gap during method transfer – CAPA failure exposed

Addressing Analyst Training Gaps During Method Transfer: A CAPA Case Study In a recent scenario at a pharmaceutical manufacturing facility, a significant deviation occurred during the analytical method transfer from…

Sample preparation error during data review – data integrity breach analysis

Analysis of Sample Preparation Error Causing Data Integrity Breach in QC Laboratory The integrity of data generated in pharmaceutical laboratories is a foundational element of compliance and regulatory adherence. A…

Unapproved chromatographic integration during data review – data integrity breach analysis

Analysis of Unapproved Chromatographic Integration during Data Review or Insight into Data Integrity Breaches In the world of pharmaceutical manufacturing, maintaining rigorous data integrity is paramount. A recent incident at…

Backdated test records during routine testing – inspection citation explained

Understanding Backdated Test Records in Routine Testing: A Case Study In a recent incident at a pharmaceutical manufacturing facility, a critical issue arose surrounding the practice of backdating test records…

System suitability failure ignored during stability analysis – inspection citation explained

Inspection Citation Analysis: Ignoring System Suitability Failures During Stability Studies In a routine internal audit at a mid-sized pharmaceutical manufacturing company, a significant quality control (QC) deviation was identified: a…